Literature DB >> 13270188

Rauwolfia alkaloids in mental syndromes.

H AZIMA, I KENT, R A CLEGHORN.   

Abstract

Entities:  

Keywords:  MENTAL DISORDERS/therapy; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh：

Substances：

Year:  1955        PMID： 13270188      PMCID： PMC1826290     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  An extrapyramidal syndrome with reserpine.

Authors:  A RICHMAN; J S TYHURST
Journal:  Can Med Assoc J       Date:  1955-03-15       Impact factor: 8.262

2.  Effects of largactil in mental syndromes.

Authors:  H AZIMA; W OGLE
Journal:  Can Med Assoc J       Date:  1954-08       Impact factor: 8.262

3.  The Current Transition in the Conception of Science.

Authors:  D E Cameron
Journal:  Science       Date:  1948-05-28       Impact factor: 47.728

4.  Use of Rauwolfia serpentina Benth. in neuropsychiatric conditions.

Authors:  N S KLINE
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

5.  A clinical trial of Rauwolfia serpentina in essential hypertension.

Authors:  R J VAKIL
Journal:  Br Heart J       Date:  1949-10

6.  Reserpine (serpasil) in the management of the mentally ill and mentally retarded; preliminary report.

Authors:  R H NOCE; D B WILLIAMS; W RAPAPORT
Journal:  J Am Med Assoc       Date:  1954-10-30
  6 in total
  2 in total

1.  The hierarchical methodological approach to psychopharmacology.

Authors:  H AZIMA
Journal:  Psychiatr Q       Date:  1961-04

2.  The use of chlorpromazine and reserpine in psychological disorders in general practice.

Authors:  H AZIMA
Journal:  Can Med Assoc J       Date:  1956-06-01       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.